LOTUS EYE HOSPITAL AND INSTITUTE
|
LOTUS EYE HOSPITAL AND INSTITUTE Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.04 | 0.36 | 1.40 | 1.96 | 1.44 |
| CEPS(Rs) | 1.84 | 1.80 | 3.19 | 3.39 | 2.64 |
| DPS(Rs) | - | - | 0.50 | 0.50 | 0.50 |
| Book NAV/Share(Rs) | 28.92 | 28.85 | 28.57 | 27.69 | 26.26 |
| Tax Rate(%) | 250.00 | 46.53 | 27.39 | 27.86 | 27.09 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 6.62 | 7.18 | 13.76 | 16.35 | 15.25 |
| EBIT Margin(%) | 1.82 | 3.76 | 8.74 | 12.45 | 11.07 |
| Pre Tax Margin(%) | -0.10 | 2.79 | 8.33 | 12.01 | 10.52 |
| PAT Margin (%) | 0.15 | 1.49 | 6.05 | 8.67 | 7.67 |
| Cash Profit Margin (%) | 7.13 | 7.56 | 13.78 | 15.00 | 14.10 |
| Performance Ratios | |||||
| ROA(%) | 0.11 | 1.09 | 4.51 | 6.58 | 4.99 |
| ROE(%) | 0.13 | 1.24 | 4.98 | 7.27 | 5.56 |
| ROCE(%) | 1.47 | 3.10 | 7.19 | 10.43 | 8.00 |
| Asset Turnover(x) | 0.71 | 0.73 | 0.75 | 0.76 | 0.65 |
| Sales/Fixed Asset(x) | 0.48 | 0.49 | 0.51 | 0.53 | 0.46 |
| Working Capital/Sales(x) | 26.45 | 11.96 | 6.28 | 4.94 | 5.47 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.08 | 2.04 | 1.95 | 1.89 | 2.17 |
| Receivable days | 8.60 | 9.50 | 9.20 | 6.97 | 6.40 |
| Inventory Days | 26.04 | 25.93 | 22.72 | 19.77 | 19.16 |
| Payable days | 72.50 | 80.52 | 78.70 | 81.76 | 96.13 |
| Valuation Parameters | |||||
| PER(x) | 2,618.86 | 196.62 | 40.31 | 29.62 | 37.18 |
| PCE(x) | 55.03 | 38.80 | 17.69 | 17.11 | 20.23 |
| Price/Book(x) | 3.50 | 2.42 | 1.98 | 2.10 | 2.03 |
| Yield(%) | - | - | 0.88 | 0.86 | 0.94 |
| EV/Net Sales(x) | 4.08 | 2.86 | 2.30 | 2.39 | 2.63 |
| EV/Core EBITDA(x) | 46.31 | 29.18 | 13.95 | 12.71 | 14.99 |
| EV/EBIT(x) | 224.38 | 76.12 | 26.26 | 19.19 | 23.73 |
| EV/CE(x) | 3.03 | 2.34 | 1.86 | 1.95 | 1.67 |
| M Cap / Sales | 3.92 | 2.93 | 2.44 | 2.57 | 2.85 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.38 | 2.81 | 2.48 | 20.90 | 20.21 |
| Core EBITDA Growth(%) | -2.68 | -38.76 | -10.21 | 29.62 | 55.74 |
| EBIT Growth(%) | -47.60 | -55.79 | -28.03 | 35.94 | 102.31 |
| PAT Growth(%) | -89.12 | -74.63 | -28.52 | 36.63 | 90.33 |
| EPS Growth(%) | -89.11 | -74.63 | -28.52 | 36.62 | 90.33 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.20 | 0.01 | - | - | - |
| Current Ratio(x) | 1.22 | 1.56 | 2.21 | 2.83 | 2.24 |
| Quick Ratio(x) | 0.81 | 1.04 | 1.70 | 2.30 | 1.83 |
| Interest Cover(x) | 0.95 | 3.88 | 20.98 | 28.69 | 20.09 |
| Total Debt/Mcap(x) | 0.06 | - | - | - | - |
Compare Financial Ratios of peers of LOTUS EYE HOSPITAL AND INSTITUTE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LOTUS EYE HOSPITAL AND INSTITUTE | ₹239.1 Cr | -0.6% | 5.2% | -2.9% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹116,696.0 Cr | -8.7% | -7.4% | 6.7% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹91,963.2 Cr | -6.8% | -6.2% | -18.4% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹61,779.8 Cr | -6.7% | -6.5% | 8.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹59,332.2 Cr | -5.9% | -13.7% | -18.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,596.6 Cr | -6.4% | -10.1% | 4.2% | Stock Analytics | |
LOTUS EYE HOSPITAL AND INSTITUTE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LOTUS EYE HOSPITAL AND INSTITUTE | -0.6% |
5.2% |
-2.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses
